National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析

◆英語タイトル:National HealthCare Corp (NHC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH31620FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing care, Alzheimer’s and memory care, residential and assisted living, home care, hospice care and long term care insurance services. It provides home care services such as infusion therapy, wound care, and physical, occupational, speech therapies and rehabilitation services. In addition, NHC offers education, support and counseling to the families and caregivers of patients. The center also provides management and accounting services. It operates through its medical centers, residential living centers and assisted living communities. The center operates its homecare licensed and Medicare-certified offices in four states such as South Carolina, Missouri and Florida, the US. NHC is headquartered in Murfreesboro, Tennessee, the US.

National HealthCare Corp Key Recent Developments

Mar 02,2021: H2 Equity Partners; Acquisition of Optegra Group
Feb 19,2021: NHC releases fourth quarter 2020 earnings
Feb 19,2021: NHC releases fourth quarter 2020 earnings
Nov 24,2020: SRZ Management acquires NHC Healthcare Town & Country

This comprehensive SWOT profile of National HealthCare Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of National HealthCare Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

National HealthCare Corp – Key Information
National HealthCare Corp – Overview
National HealthCare Corp – Key Employees
National HealthCare Corp – Key Employee Biographies
National HealthCare Corp – Key Operational Heads
National HealthCare Corp – Major Products and Services
National HealthCare Corp – History
National HealthCare Corp – Company Statement
National HealthCare Corp – Locations And Subsidiaries
National HealthCare Corp
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

National HealthCare Corp – Business Description
National HealthCare Corp – Corporate Strategy
National HealthCare Corp – SWOT Analysis
SWOT Analysis – Overview
National HealthCare Corp – Strengths
National HealthCare Corp – Weaknesses
National HealthCare Corp – Opportunities
National HealthCare Corp – Threats
National HealthCare Corp – Key Competitors

Section 3 – Company Financial Performance Charts

National HealthCare Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

National HealthCare Corp, Key Information
National HealthCare Corp, Key Ratios
National HealthCare Corp, Share Data
National HealthCare Corp, Major Products and Services
National HealthCare Corp, History
National HealthCare Corp, Key Employees
National HealthCare Corp, Key Employee Biographies
National HealthCare Corp, Key Operational Heads
National HealthCare Corp, Other Locations
National HealthCare Corp, Subsidiaries
National HealthCare Corp, Key Competitors
National HealthCare Corp, SWOT Analysis
National HealthCare Corp, Ratios based on current share price
National HealthCare Corp, Annual Ratios
National HealthCare Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Humanigen Inc (HGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Humanigen Inc (Humanigen), formerly KaloBios Pharmaceuticals Inc is a biopharmaceutical company that develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company provides Ifabotuzumab(anti-EphA3) and Lenzilumab(anti-GM-CSF) recombinant monoclonal antibodi …
  • Cameco Corporation:企業のM&A・事業提携・投資動向
    Cameco Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cameco Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Andalay Solar Inc (WEST):企業の財務・戦略的SWOT分析
    Andalay Solar Inc (WEST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hecla Mining Company:企業のM&A・事業提携・投資動向
    Hecla Mining Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hecla Mining Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Zayo Group LLC (ZAYO):企業の財務・戦略的SWOT分析
    Zayo Group LLC (ZAYO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Del Frisco’s Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • F5 Networks, Inc. (FFIV):企業の財務・戦略的SWOT分析
    F5 Networks, Inc. (FFIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Zeltiq Aesthetics Inc (ZLTQ):企業の財務・戦略的SWOT分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Phagelux Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …
  • American International Group Inc:企業のM&A・事業提携・投資動向
    American International Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's American International Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • The Leukemia & Lymphoma Society Inc-製薬・医療分野:企業M&A・提携分析
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a health organization that offers funding research, finding cures and access to treatments for blood cancer patients. The organization’s services include patient support, health education, policy advocacy, funds raising and medical research fundin …
  • Pharmbio Korea Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmbio Korea Co Ltd (Pharmbio) is a pharmaceutical company that manufactures and markets original prescribing drugs and OTC drugs for various therapeutic segments. The company offers products in therapeutic areas of urology, gastroenterology, pediatrics, pain control, obstetrics and gynaec …
  • Rite Aid Corporation:企業の戦略・SWOT・財務分析
    Rite Aid Corporation - Strategy, SWOT and Corporate Finance Report Summary Rite Aid Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Surgical Innovations Group Plc (SUN):医療機器:M&Aディール及び事業提携情報
    Summary Surgical Innovations Group plc (Surgical Innovations) designs, develops, manufactures and markets medical devices for use in minimally invasive surgery (MIS) and industrial markets. The company offers SI branded products and products for selected original equipment manufacturer (OEM) partner …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務分析
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Wienerberger AG:企業のM&A・事業提携・投資動向
    Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆